Competitive electroporation formulation for cell therapy.
Competitive electroporation formulation for cell therapy.
复制标题
DOI:
10.1038/cgt.2011.27
复制
发表时间:
2011-08
影响因子:
6.4
通讯作者:
中科院分区:
文献类型:
--
作者:
Established cell transfection via nucleofection relies on nucleofection buffers with unknown and proprietary makeup due to trade secrecy, inhibiting the possibility of using this otherwise effective method for developing cell therapy. We devised a three-step method for discovering an optimal formulation for the nucleofection of any cell-line. These steps include the selection of the best nucleofection program and known buffer type, selection of the best polymer for boosting the transfection efficiency of the best buffer, and the comparison with the optimal buffer from an established commercial vendor (Amaxa). Using this 3-step selection system, competitive nucleofection formulations were discovered for multiple cell lines, which are equal to or surpass the efficiency of the Amaxa nucleofector solution in a variety of cells and cell lines, including primary adipose stem cells, muscle cells, tumor cells, and immune cells. Through the use of scanning electron microscopy, we have revealed morphological changes, which predispose for the ability of these buffers to assist in transferring plasmid DNA into the nuclear space. Our formulation may greatly reduce the cost of electroporation study in laboratory and boosts the potential of application of electroporation-based cell therapies in clinical trials.
登录
查看更多内容
影响因子:
12.4
作者:
Hartikka, J;Sukhu, I;Sawdey, M
通讯作者:
Sawdey, M
影响因子:
12.4
作者:
Josiah, Darnell T.;Zhu, Dongqin;Caldas, Hannah
通讯作者:
Caldas, Hannah
影响因子:
5
作者:
Cukjati, David;Batiuskaite, Danute;Mir, Lluis M.
通讯作者:
Mir, Lluis M.
影响因子:
--
作者:
Jacobsen F;Mertens-Rill J;Beller J;Hirsch T;Daigeler A;Langer S;Lehnhardt M;Steinau HU;Steinstraesser L
通讯作者:
Steinstraesser L
影响因子:
3
作者:
Leclere, PG;Panjwani, A;Tonge, DA
通讯作者:
Tonge, DA